AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4606 out of 4706 analysts
Average Return
-12.44%
Win Rate
32%29 out of 92
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | +92.73% | $147.00 | $283.32 | 2024-02-15 - 2024-10-14 | Buy |
Alnylam Pharmaceuticals IncALNY | +89.27% | $149.69 | $283.32 | 2024-02-19 - 2024-10-14 | Buy |
Alnylam Pharmaceuticals IncALNY | +83.09% | $154.74 | $283.32 | 2024-02-20 - 2024-10-14 | Buy |
Alnylam Pharmaceuticals IncALNY | +72.60% | $164.15 | $283.32 | 2024-02-13 - 2024-10-14 | Buy |
Alnylam Pharmaceuticals IncALNY | +69.30% | $167.35 | $283.32 | 2023-11-02 - 2024-10-14 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | 21 | Buy | $300.00 | +5.89% | Reiterates | 5 days ago |
Wave Life Sciences LtdWVE | 4 | Hold | $7.00 | -19.82% | Maintains | 11 days ago |
Crispr Therapeutics AgCRSP | 10 | Hold | $53.00 | +10.82% | Maintains | 11 days ago |
Biomarin Pharmaceutical IncBMRN | 10 | Hold | $80.00 | +13.85% | Maintains | 11 days ago |
Ionis Pharmaceuticals IncIONS | 6 | Buy | $70.00 | +81.21% | Reiterates | 19 days ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Buy | $77.00 | +37.04% | Reiterates | 19 days ago |
Arrowhead Pharmaceuticals IncARWR | 7 | Buy | $42.00 | +116.94% | Reiterates | 19 days ago |
Korro Bio IncKRRO | 5 | Buy | $95.00 | +142.04% | Reiterates | a month ago |
Moderna IncMRNA | 12 | Hold | $75.00 | +29.92% | Reiterates | a month ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $54.00 | +176.78% | Reiterates | a month ago |
Beam Therapeutics IncBEAM | 5 | Hold | $27.00 | +1.54% | Reiterates | a month ago |
Editas Medicine IncEDIT | 6 | Hold | $8.00 | +146.91% | Reiterates | a month ago |
Bluebird Bio IncBLUE | 4 | Hold | $4.00 | +695.23% | Reiterates | 2 months ago |
Lexeo Therapeutics IncLXEO | 3 | Buy | $24.00 | +201.51% | Reiterates | 2 months ago |
Meiragtx Holdings PLCMGTX | 4 | Buy | $9.00 | +93.97% | Maintains | 2 months ago |
Adverum Biotechnologies IncADVM | 5 | Hold | $12.00 | +55.24% | Maintains | 2 months ago |
Verve Therapeutics IncVERV | 5 | Buy | $20.00 | +297.61% | Maintains | 2 months ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | +636.84% | Reiterates | 2 months ago |
4d Molecular Therapeutics IncFDMT | 5 | Buy | $40.00 | +342.97% | Reiterates | 3 months ago |
Allogene Therapeutics IncALLO | 6 | Buy | $10.00 | +280.23% | Reiterates | 7 months ago |
Sangamo Therapeutics IncSGMO | 5 | Hold | $2.00 | +115.75% | Reiterates | 7 months ago |
Regenxbio IncRGNX | 6 | Buy | $35.00 | +243.14% | Upgrades | 7 months ago |
Uniqure NvQURE | 3 | Buy | $28.00 | +396.45% | Reiterates | 9 months ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.